What Astria Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 5 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 267,798 |
| Net activity | +0 | −267,798 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Milne Jill C. | CEO and President | Jan 23 | Disposition to Issuer · D | −4,377 | — | — | 0 |
| Violin Jonathan | Director | Jan 23 | Disposition to Issuer · D | −263,321 | — | — | 0 |
| Komjathy Andrew | Chief Commercial Officer | Jan 23 | Disposition to Issuer · D | −45 | — | — | 0 |
| Komjathy Andrew | Chief Commercial Officer | Jan 23 | Disposition to Issuer · D | −45 | — | — | 0 |
| Komjathy Andrew | Chief Commercial Officer | Jan 23 | Disposition to Issuer · D | −10 | — | — | 0 |
| Morabito Christopher | Chief Medical Officer | Apr 01 | Open-market sale · S | −10,000 | $13.59 | −$136K | 0 |
| Morabito Christopher | Chief Medical Officer | Apr 01 | Exercise / conversion · M | +10,000 | $3.87 | +$38.7K | 10,000 |
| Perceptive Advisors Llc | Director | Feb 01 | Open-market buy · P | +2,481,350 | $12.09 | +$30M | 4,873,721 |
| Morabito Christopher | Chief Medical Officer | Jan 29 | Open-market sale · S | −9,200 | $11.15 | −$103K | 0 |
| Morabito Christopher | Chief Medical Officer | Jan 29 | Exercise / conversion · M | +9,200 | $3.87 | +$35.6K | 9,200 |
| Morabito Christopher | Chief Medical Officer | Jan 26 | Open-market sale · S | −800 | $11.02 | −$8.81K | 0 |
| Morabito Christopher | Chief Medical Officer | Jan 26 | Exercise / conversion · M | +800 | $3.87 | +$3.1K | 800 |
| Perceptive Advisors Llc | Director | Dec 21 | Open-market buy · P | +740,000 | $6.20 | +$4.59M | 2,392,371 |
| Perceptive Advisors Llc | Director | Oct 16 | Open-market buy · P | +460,546 | $6.51 | +$3M | 1,611,699 |
| Perceptive Advisors Llc | Director | Oct 16 | Open-market buy · P | +614,062 | $6.51 | +$4M | 1,652,371 |
| Perceptive Advisors Llc | Director | Dec 19 | Open-market buy · P | +908,265 | $11.01 | +$10M | 1,038,309 |
| Komjathy Andrew | Chief Commercial Officer | Dec 28 | Gift · G | −45 | — | — | 10 |
| Komjathy Andrew | Chief Commercial Officer | Dec 28 | Gift · G | −45 | — | — | 55 |
| Komjathy Andrew | Chief Commercial Officer | Nov 19 | Open-market buy · P | +100 | $6.70 | +$670 | 100 |
| Violin Jonathan | Director | Sep 20 | Other Transaction · J | +263,321 | — | — | 263,321 |
Loading...